Implications of Reducing Patent Lives in the Pharmaceutical Industry and COVID Vaccine News

A UK grandmother became the world’s first recipient of the Pfizer Covid vaccine this week. What does this mean for the pharmaceutical industry? This could be seen as a moment of victory for the industry, which has received a lot of bad press in the last few years. But the prices set by the vaccine makers could also provoke accusations of profiteering. We’ll hear from former Pfizer executive John Lamattina, Thomas Cueni of the International Federation of Pharmaceutical Manufacturers, Tahir Amin of the Initiative for Medicines, Access & Knowledge, as well as Sudarshan Jain, Secretary General of the Indian Pharmaceutical Alliance.

(Image credit: Getty Images)